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ABSTRACT
Objective To explore health professionals’ experiences of 
communicating positive newborn bloodspot screening (NBS) 
results, highlight differences, share good practice and make 
recommendations for future research.
Design Qualitative exploratory design was employed using 
semi- structured interviews
Setting Three National Health Service provider organisations 
in England
Participants Seventeen health professionals involved in 
communicating positive newborn bloodspot screening results 
to parents for all nine conditions currently included in the 
newborn bloodspot screening programme in England.
Results Findings indicated variation in approaches to 
communicating positive newborn bloodspot screening results 
to parents, largely influenced by resources available and the 
lack of clear guidance. Health professionals emphasised the 
importance of communicating results to families in a way that 
is sensitive to their needs. However, many challenges hindered 
communication including logistical considerations; difficulty 
contacting the family and other health professionals; language 
barriers; parental reactions; resource considerations; lack of 
training; and insufficient time.
Conclusion Health professionals invest a lot of time and 
energy trying to ensure communication of positive newborn 
bloodspot screening results to families is done well. However, 
there continues to be great variation in the way these results 
are communicated to parents and this is largely influenced 
by resources available but also the lack of concrete guidance. 
How best to support health professionals undertaking this 
challenging and emotive task requires further exploration. 
We recommend evaluation of a more cohesive approach that 
meets the needs of parents and staff while being sensitive to 
the subtleties of each condition.
Trial registration number ISRCTN15330120
INTRODUCTION
Newborn bloodspot screening (NBS) seeks 
to identify presymptomatic babies that are 
affected by genetic or congenital condi-
tions;1 early diagnosis leads to better health 
outcomes for the child.1 2 In January 2015, 
NBS in England and Wales expanded and 
now covers nine conditions: sickle cell disease 
(SCD); cystic fibrosis (CF); phenylketonuria 
(PKU); homocystinuria (HCU); glutaric acid-
uria type 1 (GA1) medium- chain acyl- CoA 
dehydrogenase deficiency (MCADD), maple 
syrup urine disease (MSUD), isovaleric acid-
uria (IVA) and congenital hypothyroidism 
(CHT).
In the UK, parents are given informa-
tion prior to and after birth and are asked 
to provide informed consent for their baby 
to take part in the NBS programme. NBS 
involves a small amount of blood being taken 
from the baby’s heel on day 5 of life. Each 
Strengths and limitations of this study
 ► Health professionals involved in the present study 
were employed in three different National Health 
Service organisations, increasing transferability of 
the findings and were very experienced, supporting 
families for on average 10 years.
 ► Participants were recruited via email; those with a 
pre- existing interest in this topic may have been 
more likely to self- select into the study. These peo-
ple may communicate results differently than pro-
viders who did not participate in the study.
 ► Health professionals were recruited from clinical 
teams involved in managing all nine conditions cur-
rently included in the newborn bloodspot screening 
programme in England; previous work has mainly 
focussed on cystic fibrosis and sickle cell disease.
 ► The study design, data collection and analysis were 
influenced by members of the patient and public 
involvement advisory group and relevant charities.
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year, around 10 000 parents(the term ‘parents’ refers to 
parents, carers or guardians) of babies born in the UK 
are given a positive NBS result. This happens around 2 
to 8 weeks after birth, depending on the condition.3 4 
Parents are informed of the NBS result, normally on the 
same day it becomes available, and are asked to bring 
their baby to a particular hospital for diagnostic testing 
within a given timeframe depending on the suspected 
condition.
National Guidance regarding the content and mode of 
communication between health professionals (HPs) and 
parents is generic and vague.1 5 Communication of posi-
tive NBS results is often delivered by specialist nurses and 
is a subtle and skilful task which demands thought, prepa-
ration and evidence to minimise potentially harmful 
negative sequela.6–10 However, training for this role is 
challenging due to the fact that for many of conditions, 
a positive result occurs relatively infrequently and may be 
communicated by several members of the appropriate 
team of people.
There is evidence of variations both nationally and 
internationally with regard to the approaches used to 
communicate positive NBS results particularly in rela-
tion to CF and SCD.8 10–12 These variations include the 
different approaches used to communicate the results 
(such as in person during a home visit or by letter),11 13 
the choice of person or profession to deliver the result 
and the content of the communication.14–18
The findings of Kai et al’s study13 informed the devel-
opment of the current national guidelines for the 
communication process in the NBS programme,1 5 which 
recommend face- to- face communication by an appro-
priately trained HP. Despite these guidelines, a study 
reporting the findings from 67 interviews with parents 
about their experience of receiving CF or SCD carrier 
results following NBS indicated that disparity continues 
to exist regarding how the guidelines are implemented 
in practice.7 The findings also indicated variability in 
the content and the way the result was communicated 
which led to increased parental anxiety and distress; 
the perceived lack of knowledge of the person commu-
nicating the result was potentially more distressing than 
the positive finding.7 This highlights the importance of 
understanding varied practice in order to identify, share 
and recommend good practice.
The purpose of this work was to explore HPs’ experi-
ences of communicating positive NBS results to highlight 
differences, share good practice and make recommen-
dations for future research. Experiences of parents are 
reported elsewhere.19
METHODS
A qualitative exploratory design was employed using 
semi- structured interviews as part of a large ongoing 
programme of work.20
Setting
Study sites consisted of three National Health Service 
provider organisations in England that process compa-
rable numbers of positive NBS reports annually for each 
of the nine conditions currently included in the NBS 
programme. These consisted of two in Greater London 
(served by one NBS laboratory processing 128 positive 
NBS results in 2017/2018) and one in the West Midlands 
(whose NBS laboratory processed 129 positive NBS results 
in 2017/2018).
Patient and public involvement
Patient and public involvement (PPI) was instrumental in 
the design and conduct of this work. Parents of babies 
who had received a positive NBS screening result for one 
of the nine screened conditions formed a PPI advisory 
group who met prior to, during and following data collec-
tion. Their suggestions were incorporated into the study 
design, the data collection tools and the data analysis and 
presentation. In addition, views of representatives from 
charities for the screened conditions including Metabolic 
Support UK, the British Thyroid Foundation, the CF 
Trust and the Sickle Cell Society were also sought. These 
groups were able to provide advice on sampling methods, 
choice of study sites and the analysis and presentation of 
parental interview responses.
Inclusion and exclusion criteria
HPs involved in communicating positive NBS results in 
the previous 6 months were invited to take part in the 
study. HPs who had not been involved in communicating 
positive NBS results in the last 6 months or who had 
personal experience of receiving a positive NBS result 
were excluded.
Recruitment and sampling
A two- stage sampling approach was employed where 
participants were first sampled purposively based on their 
experience with the phenomena of interest, followed by a 
second stage of snowball sampling where the first partic-
ipants suggested others. Members of relevant clinical 
teams (medical consultants; general paediatricians; nurse 
specialists; specialist screening nurses) were initially iden-
tified through individual Trust websites and contacted 
via email and invited to participate. If no response was 
received, a follow- up email was sent after 1 week. Identi-
fied HPs were asked if there were any other members of 
the clinical teams that the research team should contact 
to ensure views were representative. All potential partici-
pants were given the choice to participate or not and were 
reminded of their right to withdraw from the study at any 
time. Written informed consent was obtained from all 
participants ahead of the interview.
Data collection
Semi- structured, face- to- face interviews comprising closed 
and open- ended questions were conducted by JC and HC 
from September 2018 to March 2019, to explore HPs 
experiences of communicating positive NBS to families. 
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Interviews took place at the participants’ place of work in 
a location and at a time of their choice. Topics covered 
included how HPs manage communication, examples of 
situations when it has gone well or not as well as expected 
and the possible reasons for this. We also explored how 
participants felt during the experience and asked for 
any suggested changes to practice. Interviews were audio 
recorded and transcribed verbatim.
Data analysis
Interviews were analysed for themes.21 An inductive 
approach to data analysis was used and themes generated 
using a latent approach21 to provide a deeper under-
standing of approaches used to communicate positive 
NBS results to families. The six phases of thematic anal-
ysis described by Braun and Clarke21 guided data analysis.
Two members of the research team (JC and HC) coded 
one interview transcript separately. These codes were then 
compared with inform and align code development22 and 
a code book was developed. A further four transcripts 
were then coded separately by the same two members of 
the research team using the code book. These separately 
coded transcripts were then compared; inter- coder reli-
ability was 84%. Following this, the same two members of 
the research team coded the remainder of the transcripts 
using the code book. Once this initial coding had been 
completed, all data for each code were compared with 
to ensure consistency in coding and to enable the codes 
to be collapsed into themes. All quotes for each theme 
were collated to inform theme development. This was an 
ongoing, iterative process; new codes were developed and 
the definition of codes refined as analysis progressed.23
Positionality and reflexivity
Members of the study team (JC, JRB, LM, FU, MB, KWS) 
have been involved in or continue to undertake a variety 
of roles and activities associated with the NBS programme 
in the UK. It is acknowledged that this could have led 
to potential bias during data collection and analysis. 
However, this was balanced by other members of the 
research team who had previously had minimal involve-
ment in NBS (HC, EKO, AS, SM). Data collection and 
analysis was mainly undertaken by JC and HC who fall 
within both camps. Neither JC nor HC were employed 
in the same organisations where data collection was 
undertaken.
RESULTS
In total, 20 HPs were emailed and invited to participate. 
Two HPs did not respond to the invitation and one HP 
did not communicate the initial positive screening result 
and was therefore ineligible. Therefore, 16 face- to- face 
interviews were conducted with 17 HPs (two requested to 
be interviewed together); 8 were from the West Midlands 
and the remaining 9 were split across the two Greater 
London Trusts. Participants with experience of all the 
nine screened conditions were included. Interviews lasted 
on average 37 min (range 19 to 58 min). The sample 
consisted of eight medical consultants, one medical regis-
trar, seven nurse specialists/advanced nurse practitioners 
and one screening nurse. Length of experience with 
newborn screening ranged from 2 to 38 years (median 
8 years)
Five themes were identified: communication between 
HPs; process of communicating with the family; parent 
and family- centred care; availability of resources and chal-
lenges to effective communication. Illustrative quotations 
are used to support the themes.
Communication between HPS
HPs reported a range of communication approaches to 
ensure sufficient information was available to them prior 
to communicating with families. This started with the labo-
ratory communicating the result to the relevant clinical 
team in a variety of ways. These included a letter, normally 
via email or a telephone call followed by an email or a 
personal visit from a member of the screening laboratory 
to the clinical nurse specialist, the screening nurse, the 
on- call consultant or the named consultant depending on 
the condition, local resources and agreements.
So we tend to find out from the newborn screening 
nurses. So, they’ll be alerted by the labs and then they 
would give us [the physician] a call (SS1P202)
The written initial communication consisted of a pro 
forma which was often developed locally and may or may 
not have been accompanied by a copy of the NBS card.
…generally, we get a pro forma from the screening 
lab that’s slightly different I think depending on the 
screening lab.(SS2P206)
We actually started asking for the card. (SS2P201&02)
Receiving a copy of the NBS card was viewed favour-
ably as it enabled HPs to check referral information and 
parental contact details if this were found to be ambig-
uous in any way.
Often, this would initiate a two pronged approach 
where HPs would commence gathering additional infor-
mation about the child and family from health visitors 
(registered nurses or midwives who have undertaken 
additional training and work mainly with children from 
birth to 5 years and their families), midwives and/or 
primary care physicians before contacting the family.
Sometimes, it is good to know, the family dynamics, 
social care issues, etc, from somebody [the health vis-
itor or midwife] who’s already involved with the fam-
ily. (SS1P203)
However, clinicians sometimes found it challenging 
to make contact with health visitors and/or midwives to 
gather additional information about the family.
…quite often we are leaving messages to ask them 
[the health visitor or midwife] to call us back and 
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quite often we are receiving those calls back, after 
we’ve already visited the family. (SS1P203)
Simultaneously, members of the multi professional 
team would also be contacted such as the physiotherapist, 
dietician or pharmacist (depending on the condition) 
to inform them that the child would be attending the 
hospital either the same or the following day.
The CF nurse specialist would let other members 
of the team know, so the physio and dietician know 
that there was a new baby, positive screen so that they 
could be on standby, but not necessarily to see the 
family. (SS1P201)
Similarly, if the plan was to see the child in a local 
hospital rather than in a tertiary care centre, similar 
communication would happen between the specialist 
centre and local clinical teams.
Process of communicating with the family
The initial contact with the family was undertaken in a 
variety of ways by different members of the clinical team. 
This included, face- to- face contact in the family’s home, 
via telephone, text message or letter from the screening 
nurse, relevant clinical nurse specialist or medical consul-
tant. Some respondents commented that they felt the 
person who told the family should not be a member of 
the specialist clinical team who would go on to care for 
the child and they felt this may taint any ongoing rela-
tionship. Others felt it was important that the person who 
gave the initial positive NBS result should be part of the 
child’s clinical team to start building familiarity and conti-
nuity of care or that there should be someone present 
who is known to the family.
So the ideal is that either the midwife or the health 
visitor can come on the visit so that somebody in the 
family already knows. (SS1P203)
Views regarding how the initial communication with 
the family was conducted varied. Some clinicians felt it 
should be face- to- face as it allowed the clinician to gather 
information about the family that would help to inform 
the follow- up visit at the hospital with the clinical team.
You just don’t know what’s going on in the home en-
vironment and you’ve, sort of, been and witnessed it 
for yourself and it just gives you a good insight into 
the family dynamics or what’s going on or what sup-
port mechanism are in place. You can’t get that over 
the telephone. (SS1P202)
Others felt that a telephone call would be more appro-
priate to ensure families were told as soon as possible 
while some felt that a text message asking the family to 
call them back had worked really well and that a home 
visit may be quite intrusive. This suggests that sometimes, 
the approach to communication may not be steered 
wholly by the needs of the family but sometimes the expe-
rience of the person communicating the result.
You can’t really get rid of anyone in someone’s house, 
can you?…You’d be a bit like, ‘Right, go now from 
my house. Get out of my house’…how scary must 
it be for somebody to turn up on your doorstep 
(SS2P201&02)
Regardless of who or how the initial communication 
took place, all respondents acknowledged the impor-
tance of ‘getting it right’. Respondents felt it was impor-
tant the person giving the positive screening result to the 
family was knowledgeable about the condition they would 
be discussing with the family. Indeed, many felt this was 
more important than how the information was delivered 
and could influence perceptions of ongoing care.
I think the most important thing, in my opinion, is 
that the person giving that information, the first time, 
needs to be someone that can answer some questions. 
(SS1P207)
I think that first telephone call and the first time you 
see them is absolutely critical…I think the family’s 
views of what’s going to come next will be completely 
modified by how it’s done and their confidence in 
the service. (SS2P206)
However, it was also acknowledged that although various 
guidelines and protocols existed for the laboratory staff 
when processing the NBS card and for treatment and 
management once the child had been diagnosed, there 
was a paucity of guidance regarding communication of 
the initial positive NBS result.
We’ve got all the protocols around timelines and 
KPIs, etc, but the one bit we don’t have anything 
concrete about is who breaks the news, what level of 
training or experience they need to have before they 
do it and what the expectation is of what they should 
cover in that visit. (SS1P203)
Consequently, the content of the initial communica-
tion also varied considerably. Some clinicians spoke about 
having a template they followed which helped them to 
ensure they imparted all the information required during 
what could sometimes be a very emotive interaction. Most 
agreed that they would try to keep the information about 
the suspected condition during the initial communi-
cation quite brief due to the fact it is a screening result 
and therefore it would not be appropriate to give too 
much information about a condition that had not been 
confirmed. In addition, families were often perceived as 
being unable to absorb the information very well due to 
the shock of an unexpected result. Finally, clinicians knew 
that when families are seen the same or following day, 
they would receive a lot more information and therefore 
were reluctant to overload them with information during 
the first contact.
So we always have said, ‘Screening will be rechecked. 
The bloods will be redone.’ (SS1P203)
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We don’t usually give them much information, they’re 
[the family] usually really upset. (SS2P201&02)
However, HPs did recognise the importance of sign-
posting families to additional information sources such as 
charity websites and the National NBS website following 
the initial communication and gave examples of excel-
lent practice.
We always take out suspected leaflets. They always 
get a copy of something to read. We take out a map 
for the hospital…so they know where to go to in that 
building….We leave them a letter that confirms what 
the screening result is and what that might mean for 
the baby. On the top of that letter, it has our mobile 
number and office number to give them permission 
to ring us if they were at all worrying. (SS1P203)
Parent and family-centred care
The importance of having a parent and family- centred 
approach when communicating the positive NBS result 
was emphasised by all clinicians and was considered to 
be an example of excellent practice. HPs spoke about the 
importance of the content of the initial communication. 
This was subdivided into a beginning, namely, remem-
bering to congratulate parents on the birth of their child. 
This was followed by a section focussed on tailoring the 
quantity and level of information given depending on 
the parental response, not giving too much information 
or overwhelming parents, being honest and providing 
emotional support and reassurance where needed.
So, you just have to judge how much information to 
give them and how best to support them because if 
parents are crying and upset about the diagnosis, you 
obviously have to support them in a different way to 
other parents. (SS1P205)
Finally, ending with a positive message, giving parents’ 
time and making sure the family know that the baby’s 
mother should be encouraged to bring a support person 
to the first visit. Also, the importance of treating each 
family as individuals and acknowledging the enormity of 
the task they are undertaking.
I think it’s easy, particularly if you’re tired or some-
thing, to appear a bit more routine, run of the mill, 
whereas, obviously, it’s a really big thing. This is their 
child, and this is an important piece of information, 
and it matters hugely to them. You have to try and 
reflect that in how you talk to them, rather than them 
just being another parent of another sickle baby, 
which is the danger. (SS3P206)
Some clinicians said they endeavour to find out how 
much parents already know, for instance, if they have 
another child with the condition or if they have been 
searching the Internet before embarking on any expla-
nations. Also, gauging how much families want to know 
as well as how much families are actually absorbing and 
when it is time to stop.
…there are some families that come in that want to 
know every single detail about everything and you 
try and be systematic in how you deliver that infor-
mation. There are other parents that you can tell, al-
though you’re trying to tell them things, they are not 
really taking it on board. (SS1P205)
Finally, HPs recognised the importance of supporting 
the whole family and therefore not making it the respon-
sibility of the parents to share information or educate 
other family members.
We’re there to support whoever. The home visit 
follow- up that I do, I say, ‘All are welcome, you know, 
if granny and granddad want to be there, if they’ve 
got questions, I’m happy to speak with them.’ Very 
often, grandparents, aunts and uncles are there, you 
know. I’ve been to one and people have been there 
on mass, but that’s their family support network 
and if that’s usually there in place, we don’t exclude 
anyone. I’m happy to talk to any family member. 
(SS1P202)
Availability of resources
HPs at all levels and for all conditions acknowledged a lack 
of training and related competencies in terms of breaking 
bad news to families. This resulted in screening nurses in 
particular developing their own training programme to 
address this deficit.
…we’ve had to develop some competencies….but 
because it’s so unique and there aren’t other nurses 
funded through a lab post, that there aren’t compe-
tencies around. (SS1P203)
Resources available at different hospitals also influ-
enced communication of the initial positive NBS result. 
Therefore, even if clinicians felt that offering to do a 
home visit to deliver the initial positive NBS result would 
be beneficial, the need to prioritise resources often meant 
this would not be an option.
…we don’t have the capacity [to do home visits]….I 
think it will be good if we can do that, but we definite-
ly don’t have the capacity for that. (SS2P203)
One hospital had screening nurses and part of their 
role was to deliver the initial positive NBS result to fami-
lies, usually face- to- face in their home. In the other two 
hospitals, this resource was not available and therefore 
the responsibility of delivering the initial positive NBS 
result to families stayed with the relevant clinical team. 
Even though HPs who were able to, felt very positive 
about the ability to offer home visits, these were resource 
intensive particularly when compared with the option to 
contact parents via telephone.
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Probably around 40 minutes is a quick visit. The lon-
gest visit I have been there [excluding travel] is prob-
ably about three hours. (SS1P203)
The ability to offer timely follow- up appointments with 
the clinical team both due to clinical need and also to 
alleviate parental anxiety was also viewed as important. 
However, many respondents discussed the availability of 
resources as a potential barrier to this and this seemed 
particularly evident for babies with SCD.
It can be a week if we’ve got a slot, or it can be any-
thing up to 4 to 5 weeks….I think it is a very stressful 
time and some families find that too long. (SS1P209)
For other conditions, clinical need meant that families 
were seen almost immediately by the clinical team after 
they had been given the initial positive NBS result.
So, it’s all clinically indicated….the rest of the meta-
bolic conditions will be seen the same day. (SS1P203)
Although ensuring families are seen quickly after being 
told their child has a positive NBS result was seen as 
important by the clinical team, this also posed problems 
on occasions in terms of the financial burden for families 
needing to travel to the hospital at short notice. Currently, 
there is no budget to prospectively pay for families’ travel 
expenses to attend clinic appointments which means 
that families are expected to meet these costs in the first 
instance. Although it may be possible, in certain circum-
stances, to apply to have these reimbursed at a later date, 
this does not help families who struggle to pay these costs 
up front.
…but we have had families who, it has happened 
where a family said, ‘I just don’t think I have the mon-
ey. I can’t afford to come’ and saying, ‘We’ll pay you 
back’ doesn’t help and that is difficult. (SS2P206)
Some clinicians also felt that the setting within which 
the family met the clinical team was important in terms of 
first impressions.
This room was designed that it hasn’t got a comput-
er or a phone, unlike our other consultation rooms. 
So, it’s a quiet space to deliver the news to the family. 
(SS1P202)
Availability of resources for diagnostic testing was also 
viewed as potentially problematic.
…when we started, the labs were kitted out, such that 
they would be able to offer a sweat test and a result 
the same day, any day….because of cuts…they’re 
much less flexible in terms of what they can offer. 
(SS1P201)
Therefore, although HPs felt very strongly about 
offering a parent- centred approach to communicating 
positive NBS results to parents, availability of training, 
staff and physical space could act as a barrier.
Other concerns related to practical and resource 
considerations included adding new conditions to the 
NBS programme and changes in geographical areas 
covered by screening laboratories particularly in relation 
to inherited metabolic diseases and CHT.
…they [babies with CHT] are dealt with by 15 differ-
ent centres…and I think that causes the labs quite a 
lot of problems. The labs would much prefer fewer 
centres. (SS2P207)
Challenges to effective communication
HPs in the current study were asked about their experi-
ence of communicating positive NBS result to families. 
Several staff commented on the personal and emotional 
impact of this aspect of their role.
Some can be pretty traumatic and you just feel like 
you’ve destroyed their world. (SS1P202)
It’s very emotional for me sometimes, very, very emo-
tional…the mother, a new born, holding a new born 
baby crying…based on the result you gave them…you 
wish you could change the result for them. (SS3P211)
Despite this, no formal mechanisms were in place to 
support HPs. However, all reported that they had devel-
oped their own support mechanisms within their teams.
…everyone’s very used to doing it, so everyone com-
pletely gets it and completely understands….you have 
a bit of a debrief with the consultant who’s seeing the 
family. (SS3P202)
HPs also struggled to make contact with parents for a 
variety of reasons including, the contact details on the 
NBS card being illegible, parents having moved or staying 
with relatives after the NBS sample was taken and parents 
not answering their phones.
You fill in clearly….not flipping scribbled…the name 
of the person, a first number, a second number of a 
partner or someone like that…even though we had 
a picture of the card, they hadn’t filled in any of the 
details (SS2P201&02)
It’s not being able to get in contact with people, be-
cause they’re not picking up on a random London 
number…The amount of junk calls we all get nowa-
days, these people are just not picking up the phone.
(SS2P201&02)
Once parents had been contacted, other challenges 
arose related to parental attributes. A common theme 
related to communicating with parents who did not speak 
English as a first language. This was not always apparent 
until after the clinician had attempted to make contact 
with the parent. This led to parents not understanding 
what was being communicated, the seriousness of what 
was being communicated or simply not engaging in the 
conversation due to lack of understanding.
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If English isn’t the first language, I certainly find it 
much more difficult to reassure, and try to be empa-
thetic because you’re worried about just getting the 
basic understanding across. (SS2P206)
Managing families who do not believe the diagnosis 
either because their child has no signs or symptoms or 
due to religious or cultural beliefs was also difficult. Such 
beliefs may also affect engagement with recommended 
medication and/or treatments. This was particularly 
evident for those families with a child with SCD.
They just wouldn’t accept that they’d got sickle, be-
cause they looked well. (SS1210)
…so you get a few that either don’t believe the diag-
nosis or their cultural beliefs are that God will mean 
that they don’t have to do anything medical that we 
suggest. (SS1P205)
Clinicians commented that this often led to patients 
not attending clinical appointments which also posed 
challenges in terms of monitoring.
Other challenges related directly to the NBS 
programme. The NBS programme is designed to iden-
tify babies with a higher chance of being affected by one 
of the screened conditions, often before they are symp-
tomatic, so they can start treatment as soon as possible if 
needed, and therefore improve outcomes. However, the 
need to inform parents that their baby has a positive NBS 
result for a potentially life changing and/or life limiting 
condition when the baby is asymptomatic was challenging.
You come to see the doctor because your child is un-
well, whereas, this is the opposite, in that, you’ve got 
a child who appears perfectly healthy, and you’re tell-
ing them that they’re unwell. (SS1P207)
DISCUSSION
This study furthers our understanding of HPs’ experi-
ences of communicating positive NBS results to families. 
It is clear that staff involved in communication of posi-
tive NBS results are passionate about making sure that 
although the message is distressing for parents, it is done 
well. Variation in communication practices continue 
to exist and is influenced by many factors including 
resources available but also the lack of clear guidance. 
This impacted on the methods used to communicate 
positive NBS results but also the content of the communi-
cation to parents. This is supported by previous research 
which has been conducted both nationally and interna-
tionally7 10–12 and suggests that further guidance may be 
needed to ensure a more cohesive approach which meets 
the needs of parents’ and staff while being sensitive to the 
subtleties of each condition. However, the issue of finite 
resources and the need to prioritise these also needs 
careful consideration.
An overarching message from the HPs involved in the 
present study was the desire to ensure communicating 
positive NBS result to families is parent and family- centred. 
Once HPs were aware of a positive NBS result, they spent a 
great deal of time ‘setting the scene’ by gathering informa-
tion from various sources in preparation for speaking with 
the family and organising the follow- up appointment with 
the clinical team. Often this important and necessary work 
would be time consuming and labour intensive in terms 
of identifying individuals who either obtained the original 
sample (midwives) or might have additional information 
about family dynamics (health visitor) and may be hindered 
by poor completion or lack of information on the NBS card.
Current guidance1 5 does not explicitly state who is the 
‘right’ person to communicate a positive NBS result to fami-
lies or what training or qualifications they should have and 
specific training to undertake this role is not available. While 
this does allow flexibility in terms of resources, it can lead 
to disparity in terms of parental experience of receiving the 
NBS result. There is no specific guidance regarding exactly 
what information should be shared with parents during the 
initial communication.5 While some HPs alluded to using an 
informal checklist, this was not universal and therefore may 
not lead to consistency between clinicians. However, clini-
cians did recognise the importance of the person imparting 
the result, having adequate condition specific knowledge, 
this is consistent with previous research.14 15 18 These are 
common problems that have been highlighted both nation-
ally and internationally.12 As these are not dependent on 
specific healthcare systems per se, the findings of the present 
study could also be extrapolated to screening programmes in 
other countries.
Clinicians experienced many challenges which hindered 
the communication of positive NBS results to families. This 
often stemmed from inadequate information on the NBS 
card but also parental reactions which could hinder effective 
communication. When parents are told the NBS result, their 
baby is often presymptomatic as this is one of the purposes of 
the NBS programme which means the result is often unex-
pected.10 16 17 This can make it difficult for parents to accept 
their baby may have an underlying health condition which 
can impact on treatment adherence and affect attendance 
at follow- up appointments. In addition, parental religious or 
cultural beliefs could also impact on parent’s acceptance of 
their baby’s suspected condition.10 24 These results demon-
strate the importance of always recording clear contact infor-
mation for all relevant family members on the NBS card as 
well information about the language spoken, the need for a 
translator and any relevant religious or cultural information.
The impact on HPs of communicating of positive NBS 
results to families has rarely been considered. It has been 
acknowledged that the emotional management of families 
could lead to additional stress and anxiety.25 However, HPs in 
the present study stated they found communicating positive 
NBS results to families difficult and emotive yet there were 
no formal mechanisms in place to support them. Despite 
this, HPs said they felt well supported by their colleagues. 
However, given the high levels of stress being reported by 
nurses and doctors and the reported rates of suicide among 
these professions26 27 perhaps more consideration needs 









pen: first published as 10.1136/bm





8 Chudleigh J, et al. BMJ Open 2020;10:e037081. doi:10.1136/bmjopen-2020-037081
Open access 
to be given to support staff undertaking such emotionally 
charged endeavours.
The general principles of communicating results that has 
emerged from this work could be extrapolated for other 
conditions where screening is recommended in children 
as well as breaking bad news in general. This might include 
conditions that may or may not be life altering/threatening 
but nevertheless can be distressing for parents. For example, 
delivering results of newborn hearing screening,28 findings 
from the physical examination of newborn babies (at birth 
and 6 to 8 weeks of age) including congenital cardiac abnor-
malities, congenital cataracts, cryptorchidism, developmental 
dislocation of the hip and findings from screening of chil-
dren’s eyes at 4 to 5 years of age. It may also be possible to 
extrapolate findings from the present study for the delivery of 
bad news to parents in instances such as children newly diag-
nosed with cancer or following diagnosis of chronic condi-
tions such as diabetes or epilepsy.
Strengths and limitations
The current study has numerous strengths. HPs involved in 
the present study were employed in three different trusts; 
two in Greater London and one in the West Midlands and 
were very experienced, supporting families for on average 
10 years. Clinicians with less experience may have felt even 
more strongly about the need for clearer guidance. In addi-
tion, HPs were recruited from clinical teams involved in 
managing all of the conditions currently included in the NBS 
programme. This increases the transferability of the study 
findings as previous work has mainly focussed on CF and 
SCD. In addition, the study design, data collection and anal-
ysis were influenced by members of the PPI advisory group 
and relevant charities.
Participants were recruited via email; those with a pre- 
existing interest in this topic may have been more likely to 
self- select into the study. These people may communicate 
results differently than providers who did not participate in 
the study which may have been based on the findings.
The researchers are experienced in this field which may 
have biassed data collection and analysis. Following the inter-
views, a HP event was held and the initial findings of the 
interviews were presented to the HPs who had been inter-
viewed in each site. The purpose of this was to ensure that 
the analysis accurately represented their views. Participants 
agreed that the analysis was correct and priorities identified 
were accurate.
Recommendations for practice
The findings from this study suggest a number of recommen-
dations for practice. For example, development of a compe-
tency framework for individuals involved in the process of 
communicating positive NBS results to families would ensure 
only HPs who are appropriately prepared to undertake this 
task.
In addition, development of a standard laboratory form 
for communicating positive NBS results to clinical teams 
would ensure that when results are received from several 
laboratories by one clinical team, the information provided 
by each is consistent.
The development of condition specific checklists for HPs 
involved in communicating positive NBS result to families 
would ensure that vital information is consistently relayed 
to families and less experienced staff would be supported in 
terms of the information they need to provide. These could 
also act as an aide- memoire for HPs as it is known that this 
can be a very distressing time for parents and so it would help 
them to remain focussed. In addition, this would ensure that 
clear contact information for all relevant family members 
including information about language spoken, translation 
needs and religious or cultural requirements could also be 
recorded and would be easily accessible for all member of the 
child and family’s care team.
Guidance regarding reliable sources of further informa-
tion for parents would also reduce alarm that can be caused 
by accessing unhelpful content on the Internet immediately 
after the initial communication of the positive NBS result. 
This might include the use of specifically designed applica-
tions or other forms of ‘easy to access’ and helpful online 
information for parents.
Finally, regular clinical supervision and emotional support 
for all staff engaged in such work, should be encouraged to 
ensure staff are adequately supported to undertake this chal-
lenging task.
CONCLUSION
HPs invest a lot of time and energy trying to make sure 
communication of positive NBS results to families is done 
well. However, there continues to be great variation in the 
way positive NBS results are communicated to parents and 
this is largely influenced by resources available but also the 
lack of concrete guidance. Evidence- based guidance derived 
from HPs’ and parents’ perspectives is needed to ensure 
there is parity in terms of communication practices. These 
should include, what training should be undertaken prior to 
undertaking this challenging role and guidelines related to 
what information should be relayed by whom and when. In 
addition, adequate support mechanism for HPs should be in 
place.
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